With the ever changing evolution of the gig economy, many industries have had to adjust to meet the demands of the market to continue to ensure that they were still hiring top talents, that goes for industries like Pharma and Biotech. As outlined in this Pharma Exec article published this year, Pharma has been considered the employer of choice for a long time, an industry where many employees would jumpstart their careers as they sought the opportunity to grow within a company or move comfortably to another industry employer.
We’re excited to be launching our latest feature Open Opportunities to help consultants find rewarding projects that matches their skillsets and preferences. Through the Open Opportunities marketplace, Clora is thrilled to connect you with top-tier employers and high quality projects. Simply log into your consultant account to browse all open projects.
Staff shortages have escalated in the last three months to become the top emerging risk that organizations face globally, according to Gartner, Inc.’s latest Emerging Risks Survey.
The survey of 137 senior executives in 4Q18 showed that concerns about “talent shortages” now outweigh those around “accelerating privacy regulation” and “cloud computing”, which were the top two risks in the 3rd Quarter 2018 Emerging Risk Monitor.
From Uber to Google to Facebook, the two-sided marketplace is a business model that creates value by facilitating exchanges between two or more interdependent groups, usually consumers and producers. In the case of Clora’s work within the life science sector, the two specific groups are employers and consultants.
PALO ALTO, Calif. & BOSTON--Science Exchange, the world’s leading marketplace for outsourced R&D™, today announced a strategic partnership with Clora, a technology platform that precisely matches life science companies with flexible, uniquely-qualified expertise.
This venture-backed, clinical stage company is developing novel delivery approaches to cell therapy. Their lead product is being developed to treat Acute Kidney Injury (AKI), the sudden loss of kidney function that can occur following cardiac surgery.
Clora has worked on 3 projects with this company relating to the filing of their IND and the execution of their early stage clinical programs.
This privately held biopharmaceutical company is developing new therapies for orphan diseases in ophthalmology.
Clora has worked on 9 projects with this company across 4 of its innovative ophthalmic products.
Subscribe now and receive a box filled with hand-picked awesome items